|
1
|
Zhou L: Editor in chief: Modern
Neurosurgery. Shanghai: Fudan University Press. Front Page; pp.
376–377. 2004
|
|
2
|
Ma LN, Song B and Cai JY: Research of the
killing effects of cinobufacini on MCF-7cells. Chin Pharmacol Bull.
27:37–40. 2011.(In Chinese).
|
|
3
|
Ramanathan A, Wang C and Schreiber SL:
Perturbational profiling of a cell-line model of tumorigenesis by
using metabolic measurements. Proc Natl Acad Sci USA.
102:5992–5997. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schildge S, Bohrer C, Beck K and
Schachtrup C: Isolation and culture of mouse cortical astrocytes. J
Vis Exp. 19:pii: 50079. 2013.
|
|
6
|
Grisolia S and Cleland WW: Influence of
salt, substrate, and cofactor concentrations on the kinetic and
mechanistic behavior of phosphoglycerate mutase. Biochemistry.
7:1115–1121. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scatena R, Bottoi P, Pontoglio A,
Mastrototaro L and Giardina B: Glycolytic enzyme inhibitors in
cancer treatment. Expert Opin Investig Drugs. 17:1533–1545. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones RG and Thompson CB: Tumor
suppressors and cell metabolism: A recipe for cancer growth. Genes
Dev. 23:537–548. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bustamante E, Morris HP and Pedersen PL:
Energy metabolism of tumor cell. Requirement for a form of
hexokinase with a propensity for mitochondrial binding. J Biol
Chem. 256:8699–8704. 1981.PubMed/NCBI
|
|
10
|
Ko YH, Pedersen PL and Geschwind JF:
Glucose catabolism in the rabbit VX2 tumor model for liver cancer:
Characterization and targeting hexokinase. Cancer Lett. 173:83–91.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu RH, Pelicano H, Zhou Y, Carew JS, Feng
L, Bhalla KN, Keating MJ and Huang P: Inhibition of glycolysis in
cancer cells: A novel strategy to overcome drug resistance
associated with mitochondrial respiratory defect and hypoxia.
Cancer Res. 65:613–621. 2005.PubMed/NCBI
|
|
12
|
Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW
and Gores GJ: Hypoxia stimulates proliferation of human hepatoma
cells through the induction of hexokinase II expression. J Hepatol.
42:358–364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheung EC and Vousden KH: The role of p53
in glucose metabolism. Curr Opin Cell Biol. 22:186–191. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Evans MJ, Saghatelian A, Sorensen EJ and
Cravatt BF: Target discovery in small molecule cell-based screens
by in situ proteome reactivity profiling. Nat Biotechnol.
23:1303–1307. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren F, Wu H, Lei Y, Zhang H, Liu R, Zhao
Y, Chen X, Zeng D, Tong A, Chen L, et al: Quantitative proteomics
identification of phosphoglycerate mutase 1 as a novel therapeutic
target in hepatocellular carcinoma. Mol Cancer. 9:812010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cortesi L, Barchetti A, De Matteis E,
Rossi E, Della Casa L, Marcheselli L, Tazzioli G, Lazzaretti MG,
Ficarra G, Federico M and Iannone A: Identification of protein
clusters predictive of response to chemotherapy in breast cancer
patients. J Proteome Res. 8:4916–4933. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang XB, Tang ZY, Zu XB, Qi L and Ruan
JD: Modified serum-guided immunoblotting for differential study of
prostate cancer. Zhonghua Nan Ke Xu. 16:438–444. 2010.(In
Chinese).
|
|
18
|
Saeki H, Kitao H, Yoshinaga K, Nakanoko T,
Kubo N, Kakeji Y, Morita M and Maehara Y: Copy-neutral loss of
heterozygosity at the p53 locus in carcinogenesis of esophageal
squamous cell carcinomas associated with p53 mutations. Clin Cancer
Res. 17:1731–1740. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao H, Yu B, Yan Y, Shen J, Zhao S, Zhu J,
Qin W and Gao Y: Correlation of expression levels of ANXA2, PGAM1,
and CALR with glioma grade and prognosis. J Neurosurg. 118:846–853.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jain R, Kulkarni P, Dhali S, Rapole S and
Srivastava S: Quantitative proteomic analysis of global effect of
LLL12 on U87 cell's proteome: An insight into the molecular
mechanism of LLL12. J Proteomics. 113:127–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
